This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
551 |
4. Check minimum number of eventsNone |
551 |
5. Include endpointsNone |
551 |
6. Filter based on genotype QC (FinnGen only) |
483 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Somnolence
based on the number of shared cases.
Similar with more cases:
- Somnolence, stupor and coma
- Condition for Implicit Sepsis (Organ dysfunction codes)
- Symptoms and signs involving cognition, perception, emotional state and behaviour
- Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 483 | 281 | 202 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | 50.86 | 44.78 | 59.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 506
- Matched controls
- 5060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R40.0
ICD-10 Finland
Somnolence
+∞
307.7
506
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
8.1
59.6
88
128
R53
ICD-10 Finland
Malaise and fatigue
4.2
55.9
247
935
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.7
49.8
146
403
N06AX16
ATC
venlafaxine; oral
4.3
44.6
144
425
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.9
43.5
73
121
N03AG01
ATC
valproic acid; systemic, rectal
6.2
43.2
82
154
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.0
40.9
67
108
AA1AD
NOMESCO Finland
CT of head and brain
3.5
40.7
210
847
N05AH04
ATC
quetiapine; oral
3.7
39.4
174
633
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.4
37.9
112
306
TAB00
NOMESCO Finland
Lumbar puncture
6.2
31.7
58
104
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.3
30.8
90
242
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.1
30.4
48
74
G40.9
ICD-10 Finland
Epilepsy, unspecified
6.9
29.1
47
74
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.5
28.2
75
187
N03AE01
ATC
clonazepam; systemic
5.5
27.5
56
111
N03AX09
ATC
lamotrigine; oral
5.1
26.2
59
128
N06AB04
ATC
citalopram; systemic
3.0
25.9
151
630
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.1
25.7
58
126
N05BA01
ATC
diazepam; systemic, rectal
3.4
25.2
106
364
G47.9
ICD-10 Finland
Sleep disorder, unspecified
6.5
24.9
42
69
N05AA02
ATC
levomepromazine; systemic
5.7
24.9
49
94
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.3
24.1
68
177
N06AX21
ATC
duloxetine; oral
3.4
24.0
101
346
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
23.7
121
466
N03AX16
ATC
[U] pregabalin
2.8
23.3
150
655
R55
ICD-10 Finland
Syncope and collapse
3.5
22.8
91
301
G47.1
ICD-10 Finland
Disorders of excessive somnolence [hypersomnias]
125.7
22.8
24
*
N05AD01
ATC
haloperidol; systemic
6.5
22.7
38
62
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.2
22.2
63
164
A04
ICPC
Weakness/tiredness general
2.9
21.6
125
514
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
8.4
21.1
28
35
A06AD11
ATC
lactulose; oral
3.0
21.0
110
427
N06AX12
ATC
bupropion; oral
3.7
20.9
74
226
G47.3
ICD-10 Finland
Sleep apnoea
2.7
20.3
147
676
R51.80
ICD-10 Finland
Headache
2.8
20.3
130
562
Z2445
NOMESCO Finland
Psychologist
4.6
20.2
51
121
G47.4
ICD-10 Finland
Narcolepsy and cataplexy
60.1
20.1
23
*
N05AX12
ATC
aripiprazole; systemic
4.7
19.9
48
110
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.5
19.8
26
32
N05AX08
ATC
risperidone; systemic
3.4
19.7
79
261
N05AF03
ATC
chlorprothixene; systemic
6.5
19.6
33
54
N05AH03
ATC
olanzapine; systemic
3.8
19.5
64
185
N06AB06
ATC
sertraline; oral
3.1
19.5
97
365
R42
ICD-10 Finland
Dizziness and giddiness
2.6
19.4
145
676
N06AB03
ATC
fluoxetine; oral
3.1
19.2
93
344
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.5
19.2
38
73
Z2446
NOMESCO Finland
Social worker
3.7
19.1
66
198
N06AA09
ATC
amitriptyline; systemic
3.6
18.8
69
215
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.5
18.6
48
116
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.3
18.5
79
271
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
18.2
78
268
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
54.6
18.1
21
*
Z3231
NOMESCO Finland
Registered nurse
2.4
17.9
175
919
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
17.9
109
457
Z2221
NOMESCO Finland
Medical doctor
2.4
17.5
172
903
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
17.5
96
380
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
17.2
76
266
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.7
17.0
58
172
N05CD07
ATC
temazepam; oral
3.1
16.9
80
291
P76
ICPC
Depressive disorder
3.4
16.9
66
214
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
3.2
16.9
73
252
XA800
NOMESCO Finland
Neuropsychological investigation
4.3
16.9
46
116
Z3226
NOMESCO Finland
Physiotherapist
2.6
16.8
122
556
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
16.6
164
861
N05BA06
ATC
lorazepam; systemic, sublingual
4.1
16.4
47
123
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.9
16.2
50
138
R41.0
ICD-10 Finland
Disorientation, unspecified
5.2
16.2
34
69
L28
ICPC
Limited function/disability (L)
2.5
15.6
113
514
F10.09
ICD-10 Finland
Alcohol intoxication UNS
6.0
15.6
28
49
N06AX11
ATC
mirtazapine; oral
2.2
15.5
202
1181
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
15.5
131
640
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
15.2
131
645
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
15.1
98
421
N06AB10
ATC
escitalopram; oral
2.3
15.0
146
757
N05BA04
ATC
oxazepam; oral
2.2
14.9
166
910
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.2
14.8
65
226
S06.0
ICD-10 Finland
Concussion
2.8
14.8
86
350
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
5.0
14.4
32
68
N06AX03
ATC
mianserin; oral
4.2
14.4
40
102
N04BC05
ATC
pramipexole; oral
3.3
14.4
57
186
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
14.3
240
1533
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
14.3
218
1345
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.6
14.2
23
36
N05AB03
ATC
perphenazine; systemic, rectal
4.9
14.2
32
69
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
14.0
95
417
N03AX12
ATC
[U] gabapentin; oral
2.5
14.0
100
450
ZY010
NOMESCO Finland
Hospital outpatient
3.4
13.9
53
169
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
13.9
89
380
R4110
NOMESCO Finland
Physiotherapy
2.2
13.7
158
874
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
4.1
13.6
39
102
C03CA01
ATC
furosemide; systemic
2.2
13.6
163
915
A28
ICPC
Limited function/disability NOS
2.4
13.6
105
490
C07AB07
ATC
bisoprolol; oral
2.0
13.5
238
1539
F10.20
ICD-10 Finland
Alcohol dependence currently independent
6.3
13.5
23
38
WX892
NOMESCO Finland
Monitored bed care
3.3
13.4
55
183
N05CF01
ATC
zopiclone; oral
2.1
13.4
177
1030
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
4.2
13.3
36
90
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
13.3
180
1056
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.1
13.2
37
95
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.0
13.2
62
224
N02BF02
ATC
pregabalin; oral
3.4
13.1
49
154
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
13.1
154
856
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.5
13.0
90
398
N03AX11
ATC
topiramate; oral
5.0
12.7
28
59
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.7
12.7
24
44
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.1
12.7
56
195
F34.1
ICD-10 Finland
Dysthymia
4.0
12.7
37
98
E86
ICD-10 Finland
Volume depletion
5.4
12.6
25
48
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.6
12.6
83
358
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.7
12.5
29
64
F33
ICD-10 Finland
Recurrent depressive disorder
4.8
12.3
28
61
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.8
12.3
28
61
N05CF02
ATC
zolpidem; oral
2.4
12.2
97
457
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.0
11.9
21
36
N02AX02
ATC
tramadol; systemic, rectal
1.9
11.7
220
1435
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
11.6
47
155
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.7
11.5
38
110
N06AX22
ATC
agomelatine; oral
4.9
11.3
25
53
N06BA07
ATC
modafinil; oral
20.6
11.2
16
8
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
11.1
45
149
N05AH02
ATC
clozapine; systemic
5.0
11.1
24
50
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
11.0
70
296
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
11.0
85
394
D12
ICPC
Constipation
4.1
11.0
31
80
R11
ICD-10 Finland
Nausea and vomiting
2.6
11.0
68
284
P03
ICPC
Feeling depressed
2.4
11.0
81
368
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.6
11.0
21
39
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
4.4
11.0
28
67
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.2
10.9
109
564
R02
ICPC
Shortness of breath/dyspnoea
2.4
10.8
81
370
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.8
10.8
34
95
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.9
10.8
24
51
R06.5
ICD-10 Finland
Mouth breathing
2.8
10.8
59
231
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.4
10.8
40
125
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.3
10.7
28
68
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
10.6
113
598
N05AN01
ATC
lithium; oral
4.6
10.6
25
56
N06AB05
ATC
paroxetine; oral
3.3
10.6
42
137
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
14.6
10.5
17
12
UKC02
NOMESCO Finland
Cystoscopy
2.3
10.5
86
409
R40
ICD-10 Finland
Somnolence, stupor and coma
+∞
10.4
10
*
N04AA02
ATC
biperiden; systemic
5.3
10.4
21
41
R50.9
ICD-10 Finland
Fever, unspecified
2.2
10.3
96
481
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.9
10.3
49
178
N06AX26
ATC
vortioxetine; oral
2.8
10.3
56
219
N06AX18
ATC
reboxetine; oral
13.5
10.2
17
13
N07BB01
ATC
disulfiram; oral
3.6
10.2
34
99
G44.2
ICD-10 Finland
Tension-type headache
2.3
10.1
89
436
N03AF02
ATC
oxcarbazepine; oral
4.1
10.0
28
72
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
10.0
135
780
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
9.9
139
812
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
9.9
117
643
H02AB06
ATC
prednisolone; systemic
1.8
9.9
237
1646
N05BA02
ATC
chlordiazepoxide; systemic
5.3
9.9
20
39
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.3
9.9
20
39
A46
ICD-10 Finland
Erysipelas
2.3
9.9
83
398
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.1
9.9
21
43
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.2
9.8
89
442
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.7
111
602
K59.1
ICD-10 Finland
Functional diarrhoea
3.2
9.7
40
134
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.2
9.6
20
40
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.9
9.6
46
168
AA40B, ,
NOMESCO Finland
22.2
9.4
13
6
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
9.4
181
1172
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
9.4
95
492
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.3
9.4
35
110
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
9.2
106
576
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.5
9.2
63
276
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.8
9.1
46
173
R07.4
ICD-10 Finland
Chest pain, unspecified
1.9
9.0
142
860
P29
ICPC
Psychological sympt/compl other
2.5
8.9
61
267
U04
ICPC
Incontinence urine
3.2
8.9
36
119
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.5
8.8
61
268
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
7.4
8.8
20
28
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.8
8.8
45
170
L17
ICPC
Foot/toe symptom/complaint
1.8
8.8
161
1023
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.7
191
1279
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.7
8.7
27
75
M79.6
ICD-10 Finland
Pain in limb
1.8
8.7
226
1592
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
8.4
8.6
18
22
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.5
8.6
30
90
N03AX18
ATC
lacosamide; systemic
16.6
8.6
13
8
N05AF05
ATC
zuclopenthixol; systemic
10.3
8.6
16
16
L03
ICPC
Low back symptom/complaint
1.8
8.6
158
1004
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.2
8.6
34
111
R25.1
ICD-10 Finland
Tremor, unspecified
4.3
8.5
22
53
R06.0
ICD-10 Finland
Dyspnoea
1.9
8.5
143
882
M79.7
ICD-10 Finland
Fibromyalgia
3.7
8.5
27
76
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.0
8.5
24
62
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
8.4
183
1222
R40.2
ICD-10 Finland
Coma, unspecified
8.8
8.4
17
20
R06AE07
ATC
cetirizine; oral
1.7
8.4
223
1577
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
8.3
55
237
N05BA09
ATC
clobazam; oral
14.8
8.2
13
9
A02BC05
ATC
esomeprazole; systemic
1.8
8.2
195
1332
RS221, ,
NOMESCO Finland
7.0
8.1
19
28
F10.25
ICD-10 Finland
Alcohol dependence continuous use
7.0
8.1
19
28
G41.9
ICD-10 Finland
Status epilepticus, unspecified
17.5
8.1
12
7
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
6.5
8.1
20
32
R4120
NOMESCO Finland
Occupational therapy
2.7
8.1
43
166
J01MA02
ATC
ciprofloxacin; systemic
1.8
8.0
186
1260
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.9
8.0
37
132
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.4
8.0
20
47
N06AX05
ATC
trazodone; oral
4.1
8.0
22
56
F32
ICD-10 Finland
Depressive episode
2.8
7.9
40
150
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
7.9
37
133
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.7
7.9
44
174
WX730
NOMESCO Finland
Conventional respirator
8.7
7.9
16
19
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
7.8
63
296
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.6
7.8
47
193
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.8
7.8
24
66
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
7.8
51
218
WX402
NOMESCO Finland
General anaesthesia
1.9
7.8
115
678
N06BA04
ATC
methylphenidate; oral
2.9
7.8
38
140
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.2
7.7
31
102
SPAT1216
SPAT
Assessment of functional ability
2.1
7.7
74
374
A01
ICPC
Pain general/multiple sites
2.3
7.7
58
265
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.1
7.7
33
113
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.6
7.6
44
177
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
7.6
42
165
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.9
7.6
36
131
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
7.6
54
241
N30.0
ICD-10 Finland
Acute cystitis
2.0
7.5
97
546
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.3
7.5
17
24
SPAT1254
SPAT
Administration of medicine
2.0
7.5
85
457
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.7
7.5
24
68
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
7.5
104
601
Z50.1
ICD-10 Finland
Other physical therapy
3.0
7.5
33
115
R13
ICD-10 Finland
Dysphagia
2.7
7.5
42
167
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
7.5
51
223
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
6.1
7.4
19
32
A02BC02
ATC
pantoprazole; systemic
1.7
7.4
322
2566
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
7.4
46
192
C03DA01
ATC
spironolactone; oral
2.2
7.4
63
303
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
7.4
112
665
L12
ICPC
Hand/finger symptom/complaint
1.9
7.4
101
580
N01
ICPC
Headache
2.0
7.4
86
467
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.1
7.4
74
380
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.3
7.4
61
290
WVA20
NOMESCO Finland
Medicine administration
3.6
7.4
24
69
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
7.3
152
994
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
7.3
48
206
C07AA05
ATC
propranolol; systemic
1.9
7.3
113
676
G43.8
ICD-10 Finland
Other migraine
4.6
7.2
17
38
NH1AD
NOMESCO Finland
Ankle and foot CT
4.6
7.2
17
38
N05BA12
ATC
alprazolam; oral
2.3
7.2
56
259
R10.2
ICD-10 Finland
Pelvic and perineal pain
4.0
7.2
20
51
S01.0
ICD-10 Finland
Open wound of scalp
2.5
7.2
46
195
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
30.5
7.2
9
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
7.2
212
1525
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
3.1
7.2
29
96
C07AB02
ATC
metoprolol; systemic
1.9
7.2
98
563
S18
ICPC
Laceration/cut
1.7
7.2
225
1644
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
8.1
7.1
15
19
N03AX14
ATC
levetiracetam; systemic
4.2
7.1
19
47
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.7
7.1
22
61
N06AX17
ATC
milnacipran; oral
10.2
7.1
13
13
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
7.1
18
43
WX290, ,
SPAT
3.4
7.1
25
76
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
4.5
7.0
17
39
F61.0
ICD-10 Finland
Mixed personality disorders
6.0
7.0
18
31
S97
ICPC
Chronic ulcer skin
2.7
6.9
38
149
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.9
129
815
P99
ICPC
Psychological disorders other
3.4
6.9
25
77
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.5
6.9
23
67
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
6.9
47
205
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.4
6.9
24
72
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.9
6.9
20
53
B01AA03
ATC
warfarin; systemic
1.9
6.8
89
502
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
6.8
74
391
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
6.8
132
844
D16
ICPC
Rectal bleeding
4.4
6.8
17
40
R4130
NOMESCO Finland
Speech therapy
3.6
6.8
22
63
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.5
6.8
23
68
P77
ICPC
Suicide/suicide attempt
40.6
6.8
8
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
4.0
6.8
19
49
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
6.8
75
400
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
22.9
6.7
9
*
R60.0
ICD-10 Finland
Localized oedema
2.1
6.7
65
330
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.4
6.6
23
69
F05.8
ICD-10 Finland
Other delirium
12.5
6.6
11
9
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.6
6.6
38
153
U06
ICPC
Haematuria
4.3
6.6
17
41
H03AA01
ATC
levothyroxine sodium; systemic
1.8
6.6
114
704
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
6.6
51
236
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
6.5
49
224
L70
ICD-10 Finland
Acne
3.5
6.5
22
65
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.1
6.5
27
91
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
6.5
33
125
E66.8
ICD-10 Finland
Other obesity
2.7
6.4
35
137
ZXE00
NOMESCO Finland
One hour or less
1.6
6.4
189
1349
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.2
6.4
17
42
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.2
6.4
17
42
I50.1
ICD-10 Finland
Left ventricular failure
2.9
6.4
29
103
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.0
6.4
27
92
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
6.4
58
287
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.3
6.4
23
71
P06
ICPC
Sleep disturbance
2.0
6.3
75
409
N06AA12
ATC
doxepin; systemic
2.7
6.3
34
132
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.9
6.3
18
47
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.0
6.3
28
98
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
6.3
62
316
Z72.8
ICD-10 Finland
Other problems related to lifestyle
18.3
6.3
9
5
T40.9
ICD-10 Finland
Poisoning: Other and unspecified psychodysleptics [hallucinogens]
+∞
6.3
6
*
R00.2
ICD-10 Finland
Palpitations
2.3
6.2
47
215
F51.0
ICD-10 Finland
Nonorganic insomnia
1.8
6.2
98
588
UJF32
NOMESCO Finland
Coloscopy
1.8
6.2
115
724
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
6.2
113
708
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
6.2
52
249
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.2
6.2
55
270
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
3.9
6.1
18
48
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.9
6.1
18
48
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
6.1
16
39
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.9
6.1
28
100
SPAT1104
SPAT
Monitoring of emergency patient
2.7
6.1
32
123
N06DA03
ATC
rivastigmine; oral, transdermal
3.0
6.1
26
89
K07
ICPC
Swollen ankles/oedema
3.0
6.1
26
89
R06.4
ICD-10 Finland
Hyperventilation
5.3
6.1
17
33
H53.1
ICD-10 Finland
Subjective visual disturbances
2.4
6.0
41
179
J01DB01
ATC
cefalexin; oral
1.8
6.0
408
3551
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
56
88
7.03
34.88
3.1
4.4
39.57
36.76
umol/l
0.16
49
81
227
1219
2.56
23.28
4.5
2.1
362.40
250.96
u/l
0.40
216
1162
47
93
5.47
23.06
1.5
1.7
3.92
3.63
mmol/l
0.95
42
86
130
529
2.96
23.01
8.7
6.4
1.08
1.05
mmol/l
0.67
124
492
314
1976
2.55
22.72
13.4
7.4
1.21
1.21
mmol/l
0.47
285
1712
287
1765
2.45
21.35
13.5
6.9
1.21
1.21
mmol/l
0.76
277
1636
102
387
3.05
20.25
6.5
4.7
1.72
1.54
mmol/l
0.18
93
319
96
356
3.09
19.80
9.1
8.2
1.30
1.38
mmol/l
0.36
96
347
43
95
4.85
18.57
2.0
1.8
3.97
15.57
e6/l
0.81
35
70
105
425
2.86
18.43
11.7
9.1
1.53
0.89
mmol/l
0.79
86
355
43
96
4.80
18.34
2.1
1.9
80.46
133.73
e6/l
0.30
37
74
89
339
2.97
17.40
9.1
7.8
8.49
8.84
mmol/l
0.19
84
327
135
637
2.53
17.39
4.1
2.4
2.45
2.31
g/l
2.17
130
591
270
1729
2.20
16.84
7.5
5.1
35.32
36.19
g/l
1.78
257
1640
141
688
2.45
16.84
4.0
2.5
13.07
13.26
umol/l
0.11
136
645
104
438
2.73
16.83
1.9
2.0
383.70
389.05
nmol/l
0.07
96
409
241
1480
2.20
16.64
4.0
3.3
28.78
31.00
u/l
0.70
231
1417
133
635
2.48
16.63
2.0
1.7
1146.98
1176.75
nmol/l
0.14
102
486
136
682
2.36
15.08
5.0
3.6
0.81
0.82
mmol/l
0.23
124
649
168
925
2.22
14.89
4.4
2.7
5.00
6.77
e6/l
0.91
151
848
197
1159
2.15
14.74
5.7
3.3
0.46
0.40
e6/l
0.14
152
847
135
695
2.29
13.96
4.5
3.1
0.66
0.96
e6/l
1.30
70
362
87
366
2.66
13.96
13.0
9.7
117.77
121.89
g/l
1.00
87
358
259
1713
2.05
13.95
2.8
2.0
97.78
94.85
pmol/l
0.42
152
911
106
494
2.45
13.73
2.4
1.9
—
—
—
0
0
328
2378
2.08
13.54
10.3
5.3
6.68
6.54
mmol/l
0.55
315
2224
190
1143
2.06
13.08
2.7
2.1
2.76
2.75
mg/l
0.01
172
995
302
2141
2.02
13.07
8.0
6.3
11.42
11.80
umol/l
0.14
293
2035
215
1356
2.02
12.95
5.8
3.4
160.97
114.84
e6/l
0.17
171
1031
84
360
2.60
12.94
2.1
2.7
0.20
0.21
g/l
0.67
74
337
72
287
2.76
12.79
5.1
4.4
103.75
78.93
ng/l
0.91
64
256
168
973
2.09
12.75
2.4
1.9
1.34
1.14
mg/l
0.20
132
744
89
402
2.47
12.26
3.4
2.6
30.14
32.59
u/l
0.28
73
332
103
500
2.33
12.07
3.1
3.1
7.77
7.75
umol/l
0.00
87
432
97
473
2.30
11.20
2.5
2.0
—
—
—
0
0
113
590
2.18
11.04
2.4
1.8
1.47
1.44
%
0.27
104
521
122
660
2.12
10.87
4.6
3.3
1.38
2.64
e6/l
1.44
57
325
20
19
10.91
10.86
2.2
6.9
603.80
134.00
umol/l
—
5
10
264
1863
1.87
10.77
3.3
2.5
73.23
74.43
nmol/l
0.31
253
1698
123
674
2.09
10.57
2.7
1.9
—
—
—
0
0
385
3091
2.03
10.37
11.3
7.7
77.97
79.63
u/l
0.32
373
2932
133
755
2.03
10.36
5.4
3.7
135.17
272.21
ng/l
0.81
97
543
351
2736
1.92
10.25
8.4
4.6
9.50
1857.85
e6/l
—
6
47
252
1777
1.83
10.08
21.8
12.9
1.29
1.22
inr
1.06
222
1496
55
218
2.71
9.83
2.4
1.5
0.17
0.36
mg/l
2.41
26
94
53
208
2.73
9.65
15.8
12.1
15.67
15.89
%
0.21
53
198
206
1383
1.83
9.53
4.0
3.1
2.35
2.35
mmol/l
0.00
189
1276
194
1286
1.82
9.31
4.3
2.6
54.73
64.55
u/l
1.05
184
1203
177
1147
1.84
9.10
2.1
1.6
20.67
20.51
nmol/l
0.05
166
989
55
230
2.56
8.83
1.9
1.5
—
—
—
0
0
314
2429
1.77
8.66
13.1
9.6
4.06
4.11
e9/l
0.17
280
2111
131
786
1.90
8.50
3.4
2.6
2.44
2.44
mmol/l
0.07
108
699
61
278
2.36
8.14
2.2
1.7
—
—
—
0
0
158
1020
1.80
8.06
5.3
3.9
1.02
1.02
kg/l
1.25
105
682
288
2200
1.72
8.05
4.8
3.1
86.97
101.54
ug/l
1.14
275
2082
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
93
3.25
7.53
2.7
2.9
0.37
0.33
iu/ml
0.21
11
48
19
33
5.94
7.29
15.7
11.8
0.65
0.62
mmol/l
0.21
19
33
30
103
3.03
6.97
1.4
1.5
—
—
—
0
0
29
98
3.08
6.92
3.6
2.2
126.30
131.37
g/l
0.49
23
79
30
104
3.00
6.86
2.9
2.8
0.95
2.32
index
1.17
18
57
46
200
2.43
6.81
6.9
4.4
54.77
49.72
%
0.70
46
195
129
821
1.77
6.75
1.9
1.7
98214769.98
23621370.08
pmol/l
0.34
112
707
101
597
1.86
6.74
2.7
2.4
102.27
116.93
ug/g
0.28
77
477
386
3273
1.76
6.69
5.9
4.3
14.25
14.56
pmol/l
1.82
362
3004
177
1238
1.66
6.53
6.0
3.9
0.00
0.01
estimate
1.23
61
467
31
113
2.86
6.50
1.3
1.3
—
—
—
0
0
14
19
7.54
6.45
1.4
1.2
—
—
—
0
0
288
2276
1.62
6.44
6.2
3.8
0.00
9.90
estimate
1.07
69
506
58
286
2.16
6.42
2.4
2.3
20.37
16.10
au/ml
—
6
22
285
2251
1.61
6.36
6.1
3.8
0.00
0.00
estimate
0.50
68
494
127
819
1.74
6.30
1.5
1.3
20.44
26.19
iu/ml
0.37
27
245
166
1153
1.65
6.24
1.5
1.3
1.75
1.87
u/ml
0.05
46
328
204
1492
1.62
6.23
7.2
3.7
138.27
39.34
ng/l
0.45
140
969
366
3085
1.67
6.18
5.5
4.2
11.68
10.94
mm/h
0.51
352
2884
40
171
2.45
6.15
1.8
1.4
—
—
—
0
0
287
2291
1.58
5.96
6.0
3.9
0.06
0.01
estimate
0.34
64
467
52
253
2.18
5.95
9.3
4.8
3.14
1.55
mmol/l
1.72
38
184
31
120
2.69
5.83
1.5
1.6
—
—
—
0
0
18
50
3.70
5.81
2.3
1.6
—
—
—
0
0
185
1343
1.60
5.72
4.1
3.6
7.16
7.95
mmol/l
1.49
163
1151
25
88
2.94
5.59
1.2
1.2
—
—
—
0
0
24
83
2.99
5.54
1.5
1.5
—
—
—
0
0
14
25
5.73
5.41
1.2
1.1
—
—
—
0
0
145
1006
1.62
5.35
2.9
2.4
—
—
—
0
0
58
307
2.00
5.33
1.4
1.4
—
—
—
0
0
30
120
2.59
5.31
1.5
1.4
243.32
302.34
ug/g
0.80
19
66
35
152
2.40
5.23
2.7
1.7
—
—
—
0
0
23
81
2.93
5.15
2.1
1.4
—
—
—
0
0
23
81
2.93
5.15
2.1
1.4
—
—
—
0
0
30
122
2.55
5.14
1.3
1.2
—
—
—
0
0
30
123
2.53
5.06
1.3
1.2
—
—
—
0
0
56
300
1.97
4.98
3.5
2.4
6.79
8.04
ug/l
0.25
51
268
144
1013
1.59
4.97
2.9
2.9
347.59
338.75
umol/l
0.42
131
911
15
41
3.74
4.96
11.3
14.6
534.07
827.63
nmol/l
2.01
15
41
15
41
3.74
4.96
1.2
1.1
—
—
—
0
0
27
107
2.61
4.88
2.7
1.6
—
—
—
0
0
248
1979
1.50
4.74
3.2
2.8
—
—
estimate
—
0
0
21
74
2.92
4.71
1.2
1.2
2.00
4.19
u/ml
—
9
27
113
759
1.63
4.69
1.4
1.3
4.06
8.62
u/ml
0.81
38
293
42
207
2.12
4.68
2.2
1.7
—
—
—
0
0
15
43
3.56
4.64
1.2
1.1
—
—
—
0
0
154
1116
1.55
4.63
4.2
3.2
1675.02
1265.38
ng/l
0.40
127
934
29
123
2.44
4.57
1.6
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
23
5.32
4.48
1.4
1.2
—
—
—
0
0
18
62
2.97
4.21
1.6
1.5
—
—
—
0
0
24
97
2.55
4.19
1.9
2.9
1.21
2.39
ratio
0.91
16
54
20
74
2.77
4.13
1.2
1.2
5.82
3.97
u/ml
0.23
11
36
25
104
2.48
4.12
1.9
3.2
45.81
109.52
mg/l
0.56
20
89
25
104
2.48
4.12
1.9
3.2
68.34
68.14
mg/l
0.00
20
89
14
36
3.97
4.02
2.5
3.0
14.67
12.40
index
—
9
25
21
82
2.63
3.93
1.4
1.3
12357.00
5977.39
e6/l
0.38
11
57
21
82
2.63
3.93
1.5
1.5
—
—
—
0
0
52
295
1.85
3.92
2.8
3.7
4.38
4.64
pmol/l
1.16
46
263
50
283
1.85
3.80
1.5
1.4
14.48
21.20
iu/l
1.46
38
240
20
78
2.63
3.76
1.5
1.6
—
—
—
0
0
20
79
2.59
3.67
4.9
2.4
9.98
7.57
pmol/l
0.52
20
79
15
51
3.00
3.60
3.5
1.6
89.72
90.69
%
0.43
15
51
19
75
2.59
3.50
14.3
12.5
105.00
105.03
mmol/l
0.01
19
67
60
370
1.71
3.44
1.6
1.3
55.85
149.64
u/ml
2.35
22
150
337
2954
1.42
3.40
5.2
3.4
51.55
44.07
u/l
0.65
320
2823
16
60
2.72
3.25
1.5
1.6
—
—
—
0
0
45
262
1.79
3.15
1.1
1.0
—
—
—
0
0
34
181
1.94
3.13
2.2
1.9
3.87
4.44
mg/l
0.15
29
133
18
74
2.49
3.08
1.4
1.4
—
—
—
0
0
8
16
5.06
3.06
2.6
1.3
—
—
—
0
0
20
87
2.35
3.04
4.2
1.9
0.84
0.93
nmol/l
0.32
20
75
25
120
2.14
3.03
3.2
3.0
—
—
—
0
0
20
88
2.33
2.97
1.3
1.5
—
—
—
0
0
17
70
2.48
2.91
1.2
1.5
—
—
—
0
0
7
13
5.44
2.87
1.9
2.9
174.57
125.46
%
—
7
13
389
3543
1.42
2.83
39.6
19.0
331.67
332.80
g/l
1.62
381
3523
212
1756
1.36
2.83
6.0
3.7
0.00
0.05
estimate
2.13
54
426
8
18
4.50
2.80
2.4
1.6
45.31
59.87
ug/l
—
8
18
12
39
3.13
2.79
1.3
1.1
—
—
—
0
0
5
6
8.40
2.75
1.4
1.2
—
—
—
0
0
11
34
3.28
2.74
1.6
1.6
—
—
—
0
0
73
502
1.53
2.71
2.3
2.1
—
—
—
0
0
6
10
6.06
2.70
1.2
1.0
84.67
95.60
%
—
6
10
60
395
1.59
2.69
8.2
3.2
—
—
—
0
0
63
420
1.57
2.68
2.2
2.0
—
—
—
0
0
437
4081
1.52
2.67
37.4
16.9
139.57
139.61
mmol/l
0.11
426
3994
415
3839
1.45
2.64
7.5
5.3
1.84
1.89
mu/l
0.37
398
3594
9
25
3.65
2.58
1.3
3.0
0.78
0.72
index
—
9
25
8
20
4.05
2.57
1.5
1.1
—
—
—
0
0
10
32
3.17
2.44
1.0
1.0
—
—
—
0
0
6
12
5.05
2.41
1.7
1.2
—
—
—
0
0
7
17
4.16
2.36
1.0
1.4
—
—
—
0
0
435
4083
1.47
2.34
37.8
17.0
3.96
3.96
mmol/l
0.03
425
3986
14
59
2.41
2.31
1.6
1.3
57.71
0.51
nmol/l
0.48
14
53
32
186
1.77
2.30
1.3
1.4
7.38
8.88
u/l
0.38
25
150
13
53
2.49
2.29
1.4
1.6
—
—
—
0
0
9
29
3.14
2.23
1.2
4.1
—
—
—
0
0
23
122
1.93
2.20
1.3
1.3
—
—
—
0
0
8
24
3.37
2.19
1.8
3.6
52.50
165.63
nmol/l
—
8
24
8
24
3.37
2.19
1.9
1.9
—
—
—
0
0
29
167
1.78
2.16
1.8
2.1
1.53
1.43
g/l
0.17
24
154
9
31
2.94
2.08
1.3
1.2
—
—
—
0
0
5
10
5.04
2.07
1.2
1.2
—
—
—
0
0
5
10
5.04
2.07
1.2
1.1
—
—
—
0
0
15
69
2.21
2.06
1.0
1.1
—
—
—
0
0
6
15
4.03
2.04
1.7
1.3
—
—
—
0
0
11
44
2.53
2.02
1.4
1.7
—
—
—
0
0
45
300
1.55
1.96
3.7
3.0
67.85
68.45
ml/min/173m2
0.03
26
125
5
11
4.58
1.94
1.0
1.2
—
—
—
0
0
5
11
4.58
1.94
1.4
1.4
—
—
—
0
0
5
11
4.58
1.94
1.4
1.3
—
—
—
0
0
126
1014
1.32
1.94
2.1
1.7
—
—
—
0
0
13
59
2.24
1.85
1.3
1.3
—
—
—
0
0
383
3563
1.31
1.83
37.0
18.6
13.73
13.52
%
2.39
378
3520
5
12
4.20
1.82
2.2
2.2
17.40
17.59
umol/l
—
5
12
8
29
2.79
1.80
2.4
1.2
116.25
101.14
pmol/l
—
8
29
17
88
1.96
1.77
1.4
2.0
—
—
—
0
0
50
696
0.69
1.75
3.2
3.1
0.65
0.80
ug/l
0.63
34
424
6
18
3.36
1.75
1.8
1.8
83.85
120.40
ng/l
—
6
18
17
90
1.92
1.67
5.9
6.3
460.40
466.70
iu/ml
—
5
10
8
31
2.61
1.66
1.5
1.2
—
—
—
0
0
7
25
2.82
1.65
1.3
3.0
1.57
1.44
%
—
7
25
23
135
1.74
1.65
1.6
1.6
0.00
0.05
iu/ml
—
6
26
8
32
2.52
1.60
1.5
1.2
—
—
—
0
0
141
1186
1.26
1.53
5.0
4.2
17.31
10.51
mg/mmol
0.76
93
769
7
27
2.61
1.52
1.3
1.4
87.29
70.33
umol/l
—
7
27
434
4139
1.34
1.52
33.7
14.7
21.09
23.17
mg/l
0.98
380
3363
6
21
2.88
1.51
3.0
3.5
429.50
682.24
u/ml
—
6
21
31
203
1.56
1.49
1.4
2.2
5.40
7.20
iu/ml
—
7
43
393
3702
1.28
1.49
7.4
5.9
39.63
38.74
mmol/mol
0.85
371
3507
9
37
2.46
1.48
1.2
1.7
—
—
—
0
0
9
37
2.46
1.48
1.2
1.7
—
—
—
0
0
9
37
2.46
1.48
1.2
1.7
—
—
—
0
0
7
28
2.52
1.45
2.4
3.6
1437.29
1176.68
mg
—
7
28
320
2952
1.23
1.43
4.2
3.4
—
—
—
0
0
99
803
1.29
1.43
2.7
2.3
—
—
—
0
0
20
119
1.71
1.39
1.4
1.1
—
4.92
—
0
23
6
23
2.63
1.37
1.0
1.1
—
—
—
0
0
38
266
1.46
1.37
1.5
1.3
—
—
—
0
0
5
17
2.96
1.36
3.4
2.4
0.33
1.27
ug/l
—
5
17
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
37
518
0.69
1.36
1.8
1.9
3.69
3.52
ratio
0.37
30
408
10
47
2.15
1.34
1.2
1.4
—
—
—
0
0
10
47
2.15
1.34
1.2
1.4
—
—
—
0
0
8
34
2.37
1.29
1.3
1.4
—
—
—
0
0
39
278
1.44
1.29
2.8
2.3
3353.42
4973.28
u/l
0.28
13
122
5
18
2.79
1.29
20.8
4.1
9.66
10.80
kpa
—
5
18
5
18
2.79
1.29
20.8
4.1
6.09
4.57
kpa
—
5
18
11
55
2.02
1.28
1.5
1.5
—
—
—
0
0
92
751
1.28
1.27
2.7
2.1
—
—
—
0
0
9
44
2.06
1.27
1.2
1.2
—
91.20
—
0
5
18
108
1.69
1.24
1.2
1.2
—
1.03
—
0
6
5
19
2.65
1.22
1.2
1.8
—
—
—
0
0
5
19
2.65
1.22
1.2
1.8
—
—
—
0
0
5
19
2.65
1.22
1.2
1.8
—
—
—
0
0
5
19
2.65
1.22
1.2
1.8
—
—
—
0
0
5
19
2.65
1.22
1.6
3.1
167.00
202.84
u/l
—
5
19
17
101
1.71
1.21
1.5
1.5
0.26
0.35
nmol/l
0.57
12
81
8
38
2.12
1.19
1.3
1.2
—
—
—
0
0
26
174
1.52
1.18
1.5
1.7
3.83
9.09
u/ml
—
6
41
11
57
1.95
1.17
1.2
1.4
—
—
—
0
0
8
40
2.02
1.12
1.0
1.8
—
—
—
0
0
33
449
0.72
1.06
5.3
4.4
31.54
31.18
%
0.07
26
317
76
920
0.80
1.06
3.9
4.4
24.35
21.93
%
0.48
30
417
444
4291
1.28
1.06
35.9
18.4
80.68
75.39
umol/l
1.28
437
4241
9
46
1.97
1.04
1.4
3.3
2.79
3.85
nmol/l
—
9
46
9
46
1.97
1.04
1.2
1.4
—
—
—
0
0
5
22
2.28
1.03
2.2
2.8
1083.00
582.73
ml
—
5
11
15
238
0.62
1.03
1.4
1.5
—
—
—
0
0
22
147
1.52
1.02
1.5
1.8
41.14
38.95
nmol/l
0.16
22
140
28
389
0.70
1.02
1.3
1.7
3.38
3.49
mmol/l
0.26
21
281
10
175
0.56
1.00
1.4
1.7
—
—
—
0
0
99
1157
0.82
0.99
4.9
5.2
1.96
2.49
ug/l
0.68
91
1030
7
37
1.90
0.94
1.0
1.2
—
—
—
0
0
6
27
2.24
0.93
3.0
2.3
—
—
—
0
0
14
86
1.65
0.91
1.3
1.5
—
—
—
0
0
18
119
1.53
0.89
1.3
1.4
191.42
242.22
u/ml
0.75
12
65
400
3845
1.19
0.87
5.9
4.6
6.01
5.84
mmol/l
1.45
372
3557
8
45
1.79
0.84
1.1
1.4
—
—
—
0
0
8
45
1.79
0.84
1.1
1.4
—
—
—
0
0
18
121
1.51
0.84
1.1
1.2
—
—
—
0
0
8
46
1.75
0.83
1.1
1.4
—
—
—
0
0
13
81
1.62
0.82
1.3
1.3
—
—
—
0
0
10
59
1.71
0.76
1.7
1.2
—
—
—
0
0
11
67
1.66
0.75
1.9
1.3
456.55
342.70
mu/l
0.39
11
54
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
441
4293
1.21
0.73
17.5
11.0
25.02
25.77
u/l
0.46
432
4184
5
25
2.01
0.73
1.2
1.5
—
—
—
0
0
7
39
1.81
0.72
1.0
1.2
—
—
—
0
0
7
39
1.81
0.72
1.0
1.2
—
—
—
0
0
5
26
1.93
0.71
1.2
1.5
—
—
—
0
0
7
42
1.68
0.68
1.4
1.1
—
—
—
0
0
7
43
1.64
0.67
1.0
1.2
—
—
—
0
0
19
137
1.40
0.65
1.7
1.3
—
—
—
0
0
5
29
1.73
0.64
1.4
1.3
189.28
163.16
pmol/l
—
5
29
12
176
0.67
0.63
1.3
1.1
0.74
0.89
g/l
1.95
12
176
8
49
1.64
0.62
1.1
1.2
—
—
—
0
0
49
414
1.20
0.55
20.5
6.3
—
—
—
0
0
12
171
0.69
0.55
1.3
1.1
1.62
1.55
g/l
0.31
12
171
6
39
1.54
0.53
1.0
1.2
—
—
—
0
0
6
41
1.47
0.50
1.0
1.6
—
—
—
0
0
9
128
0.70
0.44
1.4
1.5
44.53
52.71
ug/l
—
9
128
386
3952
0.90
0.42
5.3
4.7
4.45
4.62
mmol/l
2.79
367
3722
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
11
150
0.73
0.42
1.8
1.7
—
—
—
0
0
10
70
1.44
0.42
1.3
1.1
—
1.70
—
0
17
11
79
1.40
0.41
1.1
1.1
4.18
2.41
eliau/ml
—
6
34
0
18
0.00
0.40
0.0
1.3
—
7.46
—
0
18
5
36
1.39
0.38
1.8
1.6
—
—
—
0
0
18
143
1.27
0.37
2.7
1.8
—
—
—
0
0
14
177
0.79
0.33
1.3
1.5
—
—
—
0
0
69
757
0.90
0.33
1.7
1.5
—
—
—
0
0
18
147
1.23
0.31
3.0
2.1
—
—
—
0
0
387
3937
0.93
0.27
5.2
4.6
1.38
1.44
mmol/l
2.19
367
3690
394
4005
0.93
0.27
6.0
5.3
2.57
2.72
mmol/l
2.89
374
3761
12
95
1.27
0.26
1.3
1.2
—
—
—
0
0
8
67
1.20
0.26
1.3
1.2
—
—
—
0
0
25
216
1.17
0.26
1.8
1.3
294.09
256.87
miu/ml
0.22
11
109
9
73
1.24
0.25
1.7
1.7
—
—
—
0
0
15
180
0.83
0.24
1.3
1.5
1.34
1.18
ratio
—
9
117
15
180
0.83
0.24
1.3
1.5
1.23
1.21
ratio
—
9
117
15
180
0.83
0.24
1.3
1.5
1.00
0.95
ratio
—
9
117
5
39
1.28
0.23
7.8
3.5
—
—
—
0
0
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
13
107
1.22
0.21
2.8
2.2
10.95
11.13
mg/l
0.03
13
99
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
6
52
1.16
0.19
1.0
1.5
—
—
—
0
0
13
153
0.85
0.18
4.1
3.3
18.23
1667.53
u/ml
1.07
13
130
7
62
1.13
0.17
1.3
1.2
12.15
17.42
u/l
—
7
57
391
3863
1.05
0.17
27.0
13.8
88.26
86.06
ml/min/173m2
1.00
363
3518
8
68
1.18
0.16
1.1
1.2
—
216.67
—
0
6
14
162
0.86
0.16
1.6
1.4
—
—
—
0
0
35
379
0.92
0.15
4.0
4.0
3.51
39.03
ug/l
0.99
26
305
137
1334
1.04
0.11
4.6
3.2
0.04
0.03
estimate
0.16
51
405
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
17
155
1.10
0.09
7.6
6.4
1.44
1.39
mg/l
0.10
17
140
167
1640
1.03
0.08
2.0
1.9
1.39
1.37
mmol/l
0.14
150
1409
15
164
0.91
0.08
2.1
1.5
—
—
—
0
0
19
177
1.08
0.06
2.1
1.9
—
—
—
0
0
372
3743
0.98
0.06
4.6
4.0
1.37
1.27
mmol/l
1.54
350
3486
12
111
1.08
0.04
1.3
1.8
212.67
219.98
pmol/l
0.08
12
104
451
4505
1.01
0.00
46.2
22.4
255.39
252.17
e9/l
0.50
446
4427
451
4506
1.01
0.00
46.1
22.3
90.83
90.54
fl
0.66
446
4468
451
4509
1.00
0.00
46.2
22.4
4.41
4.51
e12/l
3.84
446
4419
451
4509
1.00
0.00
47.5
22.8
39.75
40.37
%
2.59
446
4467
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
0.48
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_SOMNOLENCE – Somnolence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).